Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial.
Costantini
Costantino O
CO
Cardiovascular Research Foundation, New York, New York 10022, USA.
Lansky
Alexandra J
AJ
Mintz
Gary S
GS
Shirai
Kazuyuki
K
Teirstein
Paul S
PS
Stone
Gregg
G
Vandertie
Lynn
L
Proctor
Brian
B
Fahy
Martin
M
Yeung
Alan
A
Raizner
Albert E
AE
Waksman
Ron
R
Leon
Martin B
MB
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000379:methods*; D001610:Beta Particles / Q000009:adverse effects / Q000627:therapeutic use*; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods*; D017023:Coronary Angiography; D003327:Coronary Disease / Q000532:radiotherapy; D023903:Coronary Restenosis / Q000209:etiology*; D003331:Coronary Vessels / Q000528:radiation effects* / Q000601:surgery; D006801:Humans; D016015:Logistic Models; D010761:Phosphorus Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D015607:Stents; D016896:Treatment Outcome
D010761:Phosphorus Radioisotopes